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Purpose: This study compared the patterns of ambulatory activity in subjects with and without intermittent claudication.
Methods: The study participants were 98 subjects limited by intermittent claudication and 129 controls who were matched
for age, gender, and race. Subjects were assessed on their ambulatory activity patterns for 1 week with a small, lightweight
step activity monitor attached to the ankle using elastic Velcro (Velcro Industries BV, Manchester, NH) straps above the
lateral malleolus of the right leg. The step activity monitor recorded the number of strides taken on a minute-to-minute
basis, the time spent ambulating, and the time and number of strides measured at low (<15 strides/min), medium (15
to 30 strides/min), and high (>30 strides/min) cadences.
Results: Subjects with intermittent claudication took fewer total strides each day than the controls (3149  1557
strides/d vs 4230  1708 strides/d; P < .001) and fewer strides at medium (1228  660 strides/day vs 1638  724
strides/day; P  .001) and high (766  753 strides/day vs 1285  1029 strides/day; P < .001) cadences. Subjects with
intermittent claudication also had a lower daily average cadence than the controls (11.8  2.9 strides/min vs 13.5  3.1
strides/min; P < .001) and spent less total time ambulating each day (264  109 min/day vs 312  96 min/day; P 
.034), primarily at medium (58  30 min/day vs 75  32 min/day; P < .001) and at high (19  17 min/day vs 30 
22 min/day; P  .001) cadences.
Conclusion: Intermittent claudication is associated with lower total daily ambulatory activity owing both to less time
ambulating and to fewer strides taken while ambulating, particularly at moderate and high cadences. ( J Vasc Surg 2007;
46:1208-14.)Peripheral arterial disease (PAD) is associated with
poor long-term survival.1-14 The poor prognosis of subjects
with PAD is further compounded by sedentary living,15-17
given that the mortality risk of sedentary subjects is more
than threefold higher than of subjects in the highest quar-
tile of physical activity.18 In addition, PAD is a leading
cause of morbidity due to ambulatory limitations associated
with intermittent claudication.19-22 Intermittent claudica-
tion afflicts 5% of the United States population aged 55
years23 and occurs during ambulation when the peripheral
circulation is inadequate to meet the metabolic require-
ment of the active leg musculature. As a consequence,
intermittent claudication leads to ambulatory dysfunction
and a decline in daily physical activities.24
Despite the impact of physical activity on morbidity and
mortality in subjects with PAD, relatively few studies have
actually quantified physical activity. Several studies found
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1208that free-living daily physical activity, measured by an accel-
erometer, was lower in subjects limited by intermittent
claudication than in age-matched controls.24,25 Although
this is a reliable26 and valid27 method to assess total daily
physical activity, it does not provide information about the
pattern in which physical activity was performed. Thus, it is
unclear whether daily physical activity is lower in subjects
with intermittent claudication because of less time spent in
physical activity, because of less intense physical activity, or
a combination of both. This information is clinically rele-
vant to understanding how intermittent claudication im-
pacts ambulation throughout the day and may lead to
insights into the appropriate exercises for improving daily
ambulation.
A major technologic advance in assessing daily physical
activity occurred with the development of a step activity
monitor (StepWatch3, Cyma Inc, Mountlake Terrace,
Wash) that can be worn at the ankle.28-32 The step activity
monitor is an ideal tool to quantify daily ambulation be-
cause it records ambulatory cadence on aminute-to-minute
basis for up to 50 days as well as time spent ambulating at
various cadences. The purpose of this study was to compare
the pattern of ambulatory activity in subjects with and
without intermittent claudication.
METHODS
Subject recruitment. Subjects between the ages of 50
and 90 years were evaluated in the General Clinical Re-
search Center at the University of Oklahoma Health Sci-
ences Center (HSC) and in theHealth and Exercise Science
laboratory at the University of Oklahoma. Subjects were
recruited by referrals from the HSC vascular clinic and by
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vascular function and physical activity levels. The proce-
dures used in this study were approved by the Institutional
Review Boards at the University of Oklahoma HSC and the
University of Oklahoma. Written informed consent was
obtained from each subject before investigation.
Screening of the intermittent claudication group.
Subjects with intermittent claudication secondary to vascu-
lar insufficiency were included in this study if they had a
positive test on the San Diego Claudication Question-
naire33 and an ankle-brachial index (ABI) 0.90.23 Sub-
jects were excluded from this study for (1) absence of PAD
(ABI  0.90), (2) inability to obtain an ABI measure due to
noncompressible vessels, (3) asymptomatic PAD, (4) use of
medications indicated for the treatment of intermittent
claudication (cilostazol and pentoxifylline) 3 months be-
fore investigation, (5) exercise tolerance limited by factors
other than leg pain (eg, severe coronary artery disease,
dyspnea, poorly controlled blood pressure), and (6) active
cancer, renal disease, or liver disease. A total of 98 subjects
with intermittent claudication were deemed eligible for this
investigation, whereas 17 subjects were ineligible.
Screening of the control group. Control subjects
were included in this study if they had a negative test on the
San Diego Claudication Questionnaire, no other ambula-
tory leg pain, and an ABI 1.00. Controls were excluded
from this study for (1) an ABI 1.00, (2) inability to obtain
an ABI measure due to noncompressible vessels, (3) poorly
controlled hypertension (resting blood pressure: systolic
200 mm Hg or diastolic 120 mm Hg), (4) history of
cardiovascular disease, myocardial infarction, or stroke, (5)
history of dyspnea, (6) history of angina, and (7) active
cancer, renal disease, or liver disease. A total of 129 control
subjects were deemed eligible for this investigation,
whereas 18 subjects were ineligible.
Medical history. Demographic information, height;
weight, waist, and hip circumferences34; cardiovascular risk
factors, comorbid conditions, claudication history, and a
list of current medications were obtained during a medical
history and physical examination to begin the evaluation.
Ankle-brachial index. After 10 minutes of supine
rest, the ankle and brachial systolic blood pressures were
obtained as previously described.35 Briefly, ankle systolic
pressure was measured by Doppler technique in the poste-
rior tibial and dorsalis pedis arteries of both legs. The higher
of the two arterial pressures from the more severely diseased
leg was recorded as the resting ankle systolic pressure.
Similarly, brachial blood pressure was taken from both
arms, and the arm yielding the higher systolic pressure was
recorded as the brachial systolic pressure. The ABI was then
calculated as ankle systolic pressure/brachial systolic pres-
sure. The test-retest intraclass reliability coefficient for the
measurement of ABI in our laboratory is R  0.96 for
ABI.36
6-minute walk test. Patients performed an over-
ground 6-minute walk test supervised by trained exercise
technicians, as previously described.37 The pain-free and
total distance walked during the test were recorded. Imme-diately after completion of the test, the technician recorded
whether the walking test was done continuously or discon-
tinuously and asked the subjects to rate their level of
perceived exertion while performing the test.38 The test-
retest intraclass reliability coefficient is R  0.75 for dis-
tance to onset of claudication pain and R  0.94 for the
total 6-minute walking distance.37
Walking Impairment Questionnaire. Self-reported
ambulatory ability was assessed by using the Walking Impair-
ment Questionnaire (WIQ), a validated questionnaire for
PAD patients that assesses ability to walk at various speeds
and distances and to climb stairs.39
Ambulatory activity monitoring. Daily ambulatory
activity was assessed using a small (75  50  20 mm),
lightweight (38 g) Step Watch3 monitor, containing a
sensor, electronics, and a battery inside a completely sealed
and durable polycarbonate case. The step activity monitor
was programmed by placing the unit on a universal serial
bus (USB) docking station connected to a computer with
StepWatch3 Analysis Software. Ambulatory activity was
measured during 7 consecutive days in which subjects were
instructed to wear the monitor during waking hours and to
remove it before retiring to bed. The step activity monitor
was attached to the right ankle above the lateral malleolus
using elastic Velcro straps (Velcro BV, Manchester, NH)
and continuously recorded the number of steps taken on a
minute-to-minute basis.
Subjects returned the monitor at the end of the 7-day
period, and the data were downloaded into a subject file
stored in the software program. The accuracy of the step
activity monitor exceeds 99%  1% compared with hand-
tallied step counts during a 6-minute walk test performed
by a subset of 15 subjects with intermittent claudication
and 15 controls. This level of accuracy is similar to previous
reports.28-32
Outcomes. The step activity monitor quantifies am-
bulatory stride rate and time of ambulatory activity and
inactivity and characterizes short-duration bursts of activity
as well as sustained endurance ambulation. These outcome
measures were recorded each day and then averaged for the
7-day monitoring period.
The outcomes related to stride rate included the total
number of strides taken each day and the daily number of
strides taken at investigator-defined low cadence (15
strides/min),medium cadence (between 15 and 30 strides/
min), and high cadence (30 strides/min). Time-related
outcomes included the daily number of active and nonac-
tive minutes as well as the number of minutes spent ambu-
lating at low, medium, and high cadences. The outcomes
related to endurance and burst ambulatory activity in-
cluded the average strides per minute of the maximum
number of strides taken over a sliding window of 60, 30,
20, and 5 continuous minutes each day, as well as the
maximum stride rate obtained during the single highest
minute. In addition, the peak activity index was calculated,
in which the average stride rate for the top 30 minutes of
each day was obtained, regardless of whether these minutes
occurred continuously or discontinuously.
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retest intraclass reliability coefficient for the measurement
of total daily strides and total daily minutes of activity for
the 7-day period was R  0.87 and R  0.85, respectively.
In the controls, the respective intraclass reliability coeffi-
cients were R  0.94 and R  0.91.
Statistical analyses. Unpaired t tests were used to
compare differences between the subjects with and without
intermittent claudication for parametric measures, and
Mann-Whitney U tests were used to compare the groups
for nonparametric measures. Analysis of covariance was
used to assess group differences in ambulatory function and
ambulatory activity after adjusting for baseline clinical char-
acteristics that were significantly different between the two
groups. All analyses were performed using SPSS statistical
software (SPSS Inc, Chicago, Ill). Statistical significance
was set at P .05. Measurements are presented as means
standard deviations.
RESULTS
The clinical characteristics of the subjects with and with-
out intermittent claudication are summarized in Table I.
Compared with the controls, the subjects with intermittent
claudication had a lower ABI (P  .001), body mass index
(P  .031), and prevalence of obesity (P  .025); and a
higher waist/hip ratio (P .033) and prevalence of smok-
ing (P  .001), hypertension (P  .001), and hyperlipid-
emia (P  .005). Consequently, all of these measures,
except for ABI, served as covariates in subsequent analyses
to adjust for potential confounding effects when comparing
group differences in ambulatory function and ambulatory
activity. Age and diabetes were added as covariates because
group differences in subjects with and without intermittent
claudication approached statistical significance for both
Table I. Clinical characteristics of subjects with
intermittent claudication and controls
Variables*
Control
group
(n  129)
Intermittent
claudication
group (n  98) P
Age, y 64 (12) 66 (12) .099
Weight, kg 86.2 (20.4) 82.8 (17.2) .181
Body mass index 30.3 (6.3) 28.3 (6.0) .031
Waist girth, cm 98.3 (15.7) 101.5 (14.5) .240
Hip girth, cm 112.1 (14.4) 109.0 (12.6) .164
Waist/hip ratio 0.88 (0.10) 0.93 (0.10) .033
Ankle-brachial index 1.15 (0.11) 0.71 (0.21) .001
Sex, % men 46 55 .163
Race, % white 53 61 .706
Current smoking, % 10 34 .001
Diabetes, % 14 23 .070
Hypertension, % 40 70 .001
Hyperlipidemia, % 45 64 .005
Abdominal obesity,
†
% 60 52 .276
Obesity,
‡
% 49 34 .025
*Data are expressed as means (SD) unless otherwise indicated.
†Defined as a waist girth  88 cm in women and  102 cm in men.
‡Defined as a body mass index 30 kg/m2.variables (P  .099 and P  .070, respectively). The ABIwas not used as a covariate because it is a measure of PAD
severity and is not a confounder.
All of the subjects with intermittent claudication were
symptomatic during the 6-minute walk test, whereas the
controls were free of leg pain. As summarized in Table II,
fewer subjects with intermittent claudication were able to
walk continuously during the test than the controls (P 
.001): 36%walked discontinuously due to leg pain, whereas
13% of controls walked discontinuously due to overall
fatigue. The pain-free and 6-minute walk distances were
both shorter (P  .001) in the subjects with intermittent
claudication, and their rating of overall perceived exertion
was higher (P  .007). Subjects with intermittent claudi-
cation also had lower scores for the walking distance (P 
.001) and walking speed (P  .001) components of the
WIQ. Group differences in all of these measures persisted
(P .01) after adjusting for BMI, obesity, waist/hip ratio,
smoking, hypertension, hyperlipidemia, age, and diabetes.
Subjects with intermittent claudication took fewer total
strides each day than controls (P  .001) and fewer strides
at both medium (P  .001) and high (P  .001) cadences
Table II. Ambulatory function of subjects with
intermittent claudication and controls
Variables*
Control
group
(n  129)
Intermittent
claudication
group (n  98) P
6-Minute Walk
Pain-free distance, m 416 (103) 192 (131) .001
Distance (m) 416 (103) 340 (102) .001
Rating of perceived
exertion, score 12 (3) 13 (3) 0.007
Walked continuously, % 87 64 .001
Walking Impairment
Questionnaire
Distance score (%) 52 (33) 33 (32) .001
Speed score (%) 48 (27) 31 (25) .001
Stair climbing
score (%) 47 (32) 40 (32) 0.134
*Data are mean (SD) unless otherwise indicated.
Table III. Ambulatory strides recorded during a 1-week
monitoring period in subjects with intermittent
claudication and controls
Variables, mean (SD)
Control
group
(n  129)
Intermittent
claudication
group (n  98) P
Stride cadence, strides/d
Low 1308 (430) 1155 (460) .257
Medium 1638 (724) 1228 (660) .001
High 1285 (1029) 766 (753) .001
Total strides, strides/day 4230 (1708) 3149 (1557) .001
Percentage of strides (%)
At low cadence 33 (9) 40 (12) .001
At medium cadence 39 (8) 39 (8) .968
At high cadence 28 (12) 21 (12) .001(Table III). On a relative basis, the subjects with intermit-
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cadence (P  .001) and a lower percentage of strides at
high cadence (P  .001) than the controls. Similar to the
stride data, subjects with intermittent claudication also
spent less total time ambulating each day than the controls
(P  .034) and less time ambulating at medium (P  .001)
and high (P  .001) cadences (Table IV).
On a relative basis, the subjects with intermittent clau-
dication spent a higher percentage of time at low cadence
(P  .001), and a lower percentage of time at medium (P 
.007) and high (P  .001) cadences than the controls.
Subjects with intermittent claudication had a lower daily
average cadence (Table V) than the controls (P   .001) as
well as a lower peak activity index (P  .001) and a lower
maximal stride rate (P  .001) for continuous durations of
60, 30, 20, 5, and 1 minute. Group differences in all of
these measures persisted (P  .01) after adjusting for
covariates.
Several variables that were similar between groups be-
fore statistical adjustment were significantly different be-
tween groups after statistical adjustment. For example, after
adjustment, the subjects with intermittent claudication
took fewer strides (P .006) and spent less time (P .040)
ambulating at low cadence and spent more time (P .001)
being sedentary.
DISCUSSION
The major findings of this investigation were that,
compared with controls, subjects with intermittent claudi-
cation (1) took 26% fewer strides and spent 15% less time
ambulating each day, (2) had an overall 12% slower ambu-
latory pace, primarily evident at cadences15 strides/min,
and (3) had reduced cadences for both short-duration
bursts of activity as well as for activities associated with
sustained endurance ambulation.
The subjects with intermittent claudication took 1081
fewer strides and spent 48 fewer minutes ambulating each
day. This is similar to a previous investigation in our labo-
Table IV. Ambulatory durations recorded during a
1-week monitoring period in subjects with intermittent
claudication and controls
Variables, means (SD)
Control
group
(n  129)
Intermittent
claudication
group (n  98) P
Time, min/d
At low cadence 206 (66) 187 (80) .458
At medium cadence 75 (32) 58 (30) .001
At high cadence 30 (22) 19 (17) .001
Total activity 312 (96) 264 (109) .034
Sedentary time, min/d 1128 (96) 1176 (109) .382
Percentage of activity
time (%)
At low cadence 66 (9) 71 (10) .001
At medium cadence 24 (6) 22 (6) .007
At high cadence 10 (6) 7 (5) .001ratory that found that subjects with intermittent claudica-tion took 3935 fewer steps each day than controls (ie, 1967
fewer daily strides), as measured with a pedometer.24 The
greater difference found in our previous study may be
because subjects had more severe PAD than in the current
investigation and because pedometers typically overesti-
mate the actual steps taken due to a spurious recording of
nonambulatory body movements. Our results are also sup-
ported by studies showing that subjects with PAD have
lower physical activity than controls, as measured by an
accelerometer worn for 2 days and 1 week and by question-
naires that assessed activity levels during the previous week,
2 weeks, and 1 year.24,25
The lower total daily physical activity level in the sub-
jects with intermittent claudication was primarily due to
less ambulation at moderate and high cadences and to less
time spent ambulating at these paces. This is a novel find-
ing, as previous publications using accelerometers to com-
pare the daily activity of subjects with and without inter-
mittent claudication could not determine the pattern of
physical activity.24,25 This is the distinct advantage of the
step activity monitor used in this study: it records the
number of strides and the time spent at various cadences, as
well as the cadence during each minute of ambulation.
Our findings indicate that the amount of daily ambula-
tion performed at a cadence 15 strides/min is similar
between subjects with and without intermittent claudica-
tion. However, subjects with intermittent claudication ei-
ther chose to ambulate less at higher cadences or are less
capable of doing so. Thus, subjects with intermittent
claudication have difficulty ambulating at paces1 stride
every 4 seconds, which may further increase their risk of
morbidity40 and mortality1-14 and worsen their health-
related quality of life.41,42
The pattern of reduced ambulation at medium and
high cadences in subjects with intermittent claudication
agrees with our previous report that total leisure-time phys-
ical activity decreased progressively with more severe PAD,
Table V. Ambulatory cadences characteristic of bursts of
activity and sustained endurance activity in subjects with
intermittent claudication and controls
Variables, mean (SD)
Control
group
(n  129)
Intermittent
claudication
group (n  98) P
Burst activity cadence,
strides/min
Maximum 1-min 49.5 (6.8) 45.4 (7.0) .001
Maximum 5-min 34.1 (8.8) 28.8 (9.0) .001
Endurance activity
cadence, strides/min
Maximum 20-min 21.2 (8.4) 16.7 (8.0) .001
Maximum 30-min 17.7 (7.3) 14.0 (7.2) .001
Maximum 60-min 12.8 (5.5) 10.1 (5.3) .001
Peak activity index,
strides/min 30.8 (7.4) 26.2 (8.5) .001
Average cadence,
strides/min 13.5 (3.1) 11.8 (2.9) .001primarily due to less intense activities performed for a
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of physical activity agrees with objectively measured activity
in the present study, indicating that subjects with intermit-
tent claudication adopt slower ambulatory paces through-
out the day.
Subjects with intermittent claudication also had pat-
terns of slower ambulation at paces characteristic of bursts
of activity as well as of sustained endurance activity. The
maximum cadence attained for a 1-minute duration
throughout the day was 8% lower in the subjects with
intermittent claudication than in controls, and the maxi-
mum cadence for a 5-minute duration was 16% lower.
Ambulation performed for 5minutes or less is characteristic
of activities requiring short bursts of activity rather than of
more sustained, endurance-related activities. The slower
paces in the subjects with intermittent claudication suggest
that ambulatory pattern is altered preceding the onset of
symptoms. This agrees with our previous report that an
altered gait pattern in subjects with intermittent claudica-
tion favored greater stability at the expense of slower am-
bulation even before the onset of claudication.44
The maximum cadence attained for a 20-minute dura-
tion throughout the day was 21% lower in subjects with
intermittent claudication than in controls, and the maxi-
mum cadence for 30- and 60-minute durations were also
21% lower. Continuous ambulation for 20 minutes to
1 hour reflects endurance-related activities. The slower
paces in the subjects with intermittent claudication suggest
that subjects with intermittent claudication must slow their
cadence to complete activities performed for relatively long
durations. The slower rate of ambulation may be an adap-
tive strategy to prolong the onset and development of
intermittent claudication during sustained activities. Al-
though the pace during sustained daily activities is slower in
subjects with intermittent claudication, it may still provide
an adequate stimulus to elicit ambulatory benefits, because
low-intensity exercise training results in improvements sim-
ilar to high-intensity training, provided that the same
amount of work is accomplished.45
The cadence associated with the peak activity index was
15% lower in subjects with intermittent claudication. The
peak activity index represents the average stride rate for the
highest 30 minutes of each day, regardless of whether they
occurred continuously or discontinuously. Thus, the peak
activity index represents the highest 30 minutes of ambu-
latory stride rates accumulated throughout the day rather
than the highest continuous 30-minute period. The lower
peak activity index of the subjects with intermittent claudi-
cation is consistent with the findings for the maximum
cadence at 20, 30, and 60 continuousminutes and indicates
that subjects with intermittent claudication perform their
daily ambulatory activities at slower paces.
This study has several clinical implications for subjects
with intermittent claudication to improve their ambulation
using a home-based exercise program. The decreased daily
ambulation above a relatively slow threshold pace of 15
strides/min suggests that not only do subjects with inter-
mittent claudication spend less time ambulating above thispace but they also perform much of their ambulation
discontinuously on a minute-to-minute basis. For example,
it is quite likely that subjects with intermittent claudication
ambulate and rest for portions of each minute of daily
activity rather than performing continuous ambulation at a
slower pace throughout each minute. The clinical implica-
tion is that subjects with intermittent claudication may
improve their ambulation through home-based exercise
training if they simply ambulate in a more continuous
manner during daily activities, thereby increasing the num-
ber of strides taken each minute and increasing the total
number of active minutes, even if ambulation is done at
relatively slow paces that do not elicit leg pain.
A second key finding is that subjects with intermittent
claudication ambulate less in activities requiring bursts of
activity. The clinical implication to this finding is that
subjects with intermittent claudication may further im-
prove their ambulation in a home-based exercise program
by adding several minutes of rapid ambulation as a supple-
ment to their increased continuous, slow ambulation. This
combination should improve both ambulatory endurance
and ambulatory power required during many activities of
daily living.
This study has several limitations. The cross-sectional
design comparing subjects with and without intermittent
claudication does not allow causality to be established
because it is possible that subjects with intermittent claudi-
cation had slower ambulatory paces before symptoms de-
veloped. In addition, it is possible that the subjects did not
wear the step activity monitor during portions of their
waking hours, thereby resulting in an underestimate of
daily ambulation. We believe that this possibility is unlikely
because long durations in which no active minutes were
recorded during daytime hours were rarely evident from
the software graphs depicting the number of strides taken
on a minute-to-minute basis. Even during several hours of
being sedentary, a few minutes in which some strides
occurred were typically evident, indicating that the step
activity monitor had not been removed.
Another limitation is that the step activity monitor
cannot determine the type of sedentary activity that took
place during nonactive minutes. Consequently, it is not
possible to quantify the time spent in various sedentary
activities such as watching television, taking naps, and
sitting while eating. Furthermore, the step activity monitor
does not quantify nonambulatory physical activity; there-
fore, it underestimates the total amount of daily physical
activity accomplished to some extent.
The present findings are also limited to PAD patients
with intermittent claudication and may not be generalized
to patients with less severe and more severe symptoms.
However, a good proportion of the subjects with intermit-
tent claudication were women and African Americans, and
they had typical risk factors for PAD, including smoking,
diabetes, hypertension, hyperlipidemia, and obesity. Thus,
the findings of the present study can be generalized to most
subjects with intermittent claudication who typically have
numerous comorbid conditions.
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Subjects with intermittent claudication ambulate less
each day than controls, and the difference in total daily
activity is primarily due to less ambulation above a thresh-
old pace of 15 strides/min by the subjects with intermittent
claudication. In addition, subjects with intermittent clau-
dication had patterns of slower ambulation at paces charac-
teristic of bursts of activity as well as of sustained endurance
activity. We conclude that intermittent claudication is asso-
ciated with lower total daily ambulatory activity due both to
less time ambulating and to fewer strides taken while am-
bulating, particularly at moderate and high cadences.
Future research is needed to determine whether the
pattern of daily ambulatory activity changes after interven-
tions designed to improve claudication distances, such as
exercise rehabilitation, medication therapy, and interven-
tional procedures. This approach can be used to determine
whether the reduced ambulation of subjects with intermit-
tent claudication is primarily due to symptomatology or
whether it is due to complications that develop secondary
to chronic ischemic leg pain.
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